5th Gene Therapy Immunogenicity Summit 2024
Hanson Wade
20.08.2024 - 22.08.2024 The Westin Boston Seaport District, 425 Summer Street, 02210 Boston, Massachusetts, USA
Time: 8:30 AM - 4:00 PM
Conference themes
The success of gene therapy hinges on overcoming the immunogenicity challenges of viral vectors. With more viral vector-based gene therapies progressing through the pipeline, we need to seek solutions to this critical bottleneck 'here and now'.
The success of gene therapy hinges on overcoming the immunogenicity challenges of viral vectors. With more viral vector-based gene therapies progressing through the pipeline, we need to seek solutions to this critical bottleneck 'here and now'.
Scientific Society
Evvnt Promotion / evvnt
Evvnt Promotion / evvnt
Notes
URL:
Brochure: https://go.evvnt.com/2453359-0?pid=4832
Speakers: Alison Johnson | Principal Scientist | Boehringer Ingelheim, Bala Medicherla | Head, Bioanalytics | Astellas Gene Therapies, and more
URL:
Brochure: https://go.evvnt.com/2453359-0?pid=4832
Speakers: Alison Johnson | Principal Scientist | Boehringer Ingelheim, Bala Medicherla | Head, Bioanalytics | Astellas Gene Therapies, and more
Enquiries and Registration:
https://go.evvnt.com/2453359-2?pid=4832
General Medicine
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."
